Aquestive Therapeutics, Inc.

AQST

$5.35

-0.56%

2026-09-03 16:00:01 EDT-$0.03

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both ...

Historical Employee Count of AQST

Current

147

Change

+3.52%

Minimum

130

Maximum

157

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	147	10-K	Mar 4, 2026	View
Dec 31, 2024	142	10-K	Mar 5, 2025	View
Dec 31, 2023	135	10-K	Mar 5, 2024	View
Dec 31, 2022	130	10-K	Mar 31, 2023	View
Dec 31, 2021	157	10-K	Mar 8, 2022	View

Supply Chain of AQST

Upstream / Downstream / Proxies

Upstream

Active Pharmaceutical Ingredient (API) Suppliers — Buprenorphine/Naloxone (for Suboxone)Active Pharmaceutical Ingredient (API) Suppliers — Clobazam (for Sympazan)Active Pharmaceutical Ingredient (API) Suppliers — Diazepam (for Libervant)Active Pharmaceutical Ingredient (API) Suppliers — Epinephrine Prodrug (for Anaphylm)Polymer and Excipient Suppliers (PharmFilm components)Packaging Material Suppliers

Downstream

Indivior PLCNASDAQ:INDVHypera S.A.BOVESPA:HYPE3Haisco Pharmaceutical Group Co., Ltd.SZSE:002737Mitsubishi Tanabe Pharma America (MTPA)TSE:4188Zambon S.p.A.Assertio Holdings, Inc.NASDAQ:ASRTCosette Pharmaceuticals, Inc.Zevra Therapeutics, Inc. (formerly KemPharm)NASDAQ:ZVRACommave Therapeutics SAPharmanovia

Proxies

Indivior PLCNASDAQ:INDV Zevra Therapeutics, Inc.NASDAQ:ZVRA Assertio Holdings, Inc.NASDAQ:ASRTHypera S.A.BOVESPA:HYPE3

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer